PRKN and drug-induced dyskinesia: Clinically, homozygous or compound heterozygous mutations in the PRKN gene cause a predominantly early-onset slowly progressive parkinsonism, with diurnal fluctuation, dystonic features mainly involving the lower limbs, and good levodopa response, which is frequently complicated by Levodopa-induced motor fluctuations and dyskinesias [47].